-
Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing.
Kagan K, Staboulidou I, Cruz JJ, Wright D, Nicolaides K.
Ultrasound Obstet Gynecol 2010;36:542-7. -
Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:512-7. -
Maternal arterial stiffness in pregnancies affected by pre-eclampsia.
Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH.
Am J Physiol Heart Circ Physiol 2009;297:759-64. -
Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;34:14-8. -
Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21.
Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:657-64. -
Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:259-64. -
Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation.
Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:18-22. -
The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A MoM in normal and trisomy 21 pregnancies.
Cowans NJ, Stamatopoulou A, Maiz N, Spencer K, Nicolaides KH.
Prenat Diagn 2009;29:578-81. -
Three-dimensional sonographic calculation of the volume of intracranial structures in growth-restricted and appropriate-for-gestational age fetuses.
Benavides-Serralde A, Hernández-Andrade E, Fernández-Delgado J, Plasencia W, Scheier M, Crispi F, Figueras F, Nicolaides KH, Gratacós E.
Ultrasound Obstet Gynecol 2009;33:530-7. -
Maternal arterial stiffness in pregnancies affected by Type 1 diabetes mellitus.
Anderson JM, Savvidou MD, Kaihura C, McEniery CM, Nicolaides KH.
Diabet Med 2009;26:1135-40. -
A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:376-83. -
Effect of parity on maternal cardiac function during the first trimester of pregnancy.
Turan OM, De Paco C, Kametas N, Khaw A, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:849-54. -
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH.
Obstet Gynecol 2008;31:147-52. -
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:871-6. -
Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K.
Ultrasound Obstet Gynecol 2008;31:256-60. -
Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH.
Obstet Gynecol 2008;112:598-605. -
Maternal wave reflections and arterial stiffness in normal pregnancy as assessed by applanation tonometry.
Macedo ML, Luminoso D, Savvidou MD, McEniery CM, Nicolaides KH.
Hypertension 2008;51:1047-51. -
Maternal cardiac function and uterine artery Doppler at 11-14 weeks in the prediction of pre-eclampsia in nulliparous women.
Khaw A, Kametas NA, Turan OM, Bamfo JE, Nicolaides KH.
BJOG 2008;115:369-76. -
Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:488-92. -
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:618-24.